Download the article in PDF format *** This article explores the recent reclassification of aspartame, a widely used artificial sweetener, by the World Health Organization (WHO) as "Possibly Carcinogenic to Humans." The move has stirred varying responses from regulatory bodies, companies, and media outlets, highlighting the complexities that consumers face in discerning fact from opinion … Continue reading Aspartame Debate: Are Economic Interests Clouding the Truth?
Download the article in PDF format *** This article illustrates Dr. Samar Riaz’s doctoral research on accounting's role in reinforcing and challenging hegemonic power structures. Using Nestlé as a case study in Pakistan, the author explores how traditional accounting practices consolidate elite power at the expense of society. They draw on Antonio Gramsci's concept of … Continue reading Accounting and Hegemony in Multinational Corporations
Download the article in PDF format *** This article explores the risks associated with the irresponsible use of technology in the pharmaceutical industry, including scientific manipulation in drug trials, scientific misrepresentation through ghost-written publications, and abuse of technology through the misrepresentation of risks. The article highlights the negative impacts of these practices on patients, healthcare … Continue reading The Cost of Manipulation: The Irresponsible Abuse of Technological Opacity in the Pharmaceutical Industry
Download the article in PDF format *** Following the takeover of social media company Twitter by billionaire Elon Musk, it would not be unfair to say the company has been thrown into disarray. The litany of questionable decisions made by Musk since acquiring a $44billion controlling stake in the company on 28th October is long … Continue reading The Bonfire of Safeguards and the Potential Whistleblower Fightback at Twitter
Download the article in PDF format *** In October 2022, in the decision BTI 2014 LLC v Sequana SA  UKSC 25 the U.K. Supreme Court had the chance to re-consider the vexed question relating to the existence of a “creditor duty.” In what could be considered a reactionary judgment, the Court failed to adopt … Continue reading Corporate duty to creditors: The UK Supreme Court’s lost opportunity to adopt a more stakeholder-oriented perspective
Download the article in PDF format *** On July 21, 2022, the United Kingdom’s Competition and Markets Authority (CMA) fined pharmaceutical companies Pfizer Inc. and Flynn Pharma Limited £63 million and £6 million respectively. The fines levied against these companies are the result of them abusing their market position as a means to overcharge the … Continue reading Pfizer/Flynn medicine monopoly and the NHS: A corporate exploitation of public resources in the United Kingdom
Download the article in PDF format *** This article focuses on the innovative CSR-focused “Complementarity Matrix of 7 Responsibilities of a Company.” The French Marketing Association (Association Française du Marketing) brings together a good part of French academics that have expertise in the area of management and communication. In 2020, on the occasion of his … Continue reading The New Complementarity Matrix of 7 Responsibilities of a Company: Toward a CSR-Oriented Marketing
Download the article in PDF format *** This article is dedicated to all brave investigative journalists and public interest defenders who face challenges and even risk their lives to speak the truth. INTRODUCTION Article 10 of the European Convention on Human Rights (ECHR) confers freedom of expression - one of the most fundamental and most … Continue reading The Business of Silencing Journalists And Its Harm to the Democratic Environment